George Clinical – CRO Taiwan
George Clinical in Taiwan
Taiwan is one of George Clinical’s fastest growing Asian hubs.
With a strong growth market for drug development, dense population, and a universal healthcare system, Taiwan is an ideal location for clinical trials. George Clinical’s on the ground Clinical Team Leader oversees a number of our CRAs and CTAs in delivering customer projects across Taiwan. The Center for Drug Evaluation (CDE) was established by the Ministry of Health and Welfare (MOHW) to assist the Taiwan Food and Drug Administration (TFDA) in the technical review of new drugs, medical devices and clinical trials to fulfil regulatory requirements.
The MOHW regularly accredits sites for clinical trial conduct, where the certificate is valid for four years. There are 124 qualified sites for conducting clinical trials in Taiwan. Known centers for excellence include the National Taiwan University Hospital, which currently runs over 600 clinical trials, including 43 Phase I clinical trials; and Chang Gung Memorial Hospital, which currently runs over 500 clinical trials. There is strong government support for clinical trials.
What are the benefits of conducting clinical trials in Taiwan?
- Taiwan is a strong growth market for drug development
- Dense population
- Universal Healthcare system
- Almost 100% of Taiwanese nations are covered by the National health Insurance (NHI) program, which provides universal quality healthcare to its population at an affordable cost.
What are the prevalent diseases in Taiwan?
- Heart Disease
- Diabetes mellitus
- Chronic lower respiratory disease
- Kidney Disease
Taipei 110 Taiwan
|Number of Personnel:||6|
|In-country Services:||Clinical Operations
|Official Language:||Mandarin Chinese (official), Taiwanese (Min), Hakka dialects|
|Hospital Records Language:||English and Traditional Chinese|
|Electronic Hospital Records:||Approximately 70% of Taiwanese hospitals utilize a standard form of electronic medical records, with the number expected to increase|
|Site Network:||Only accredited teaching hospitals are able to carry out human clinical trials. There are approximately 117 teaching hospitals in Taiwan|
|GDP – per capita (US $):||$46,800|